These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36442007)

  • 21. APOE4 and Confluent White Matter Hyperintensities Have a Synergistic Effect on Episodic Memory Impairment in Prodromal Dementia.
    Kumar D; Yatawara C; Wang B; Wong B; Tan YJ; Zailan FZ; Ng KP; Kandiah N
    J Alzheimers Dis; 2022; 87(3):1103-1114. PubMed ID: 35431245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.
    Wroolie T; Roat-Shumway S; Watson K; Reiman E; Rasgon N
    J Alzheimers Dis; 2020; 75(3):903-910. PubMed ID: 32390619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
    Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
    J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.
    Carrasquillo MM; Crook JE; Pedraza O; Thomas CS; Pankratz VS; Allen M; Nguyen T; Malphrus KG; Ma L; Bisceglio GD; Roberts RO; Lucas JA; Smith GE; Ivnik RJ; Machulda MM; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Neurobiol Aging; 2015 Jan; 36(1):60-7. PubMed ID: 25189118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the content and quality of episodic future simulations in semantic dementia.
    Irish M; Addis DR; Hodges JR; Piguet O
    Neuropsychologia; 2012 Dec; 50(14):3488-95. PubMed ID: 22982607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P
    J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
    Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
    Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife.
    Rajah MN; Wallace LMK; Ankudowich E; Yu EH; Swierkot A; Patel R; Chakravarty MM; Naumova D; Pruessner J; Joober R; Gauthier S; Pasvanis S
    Neuroimage Clin; 2017; 14():760-774. PubMed ID: 28413778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    Dunk MM; Driscoll I;
    J Alzheimers Dis; 2022; 85(4):1519-1528. PubMed ID: 34958023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
    Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
    Reas ET; Triebswetter C; Banks SJ; McEvoy LK
    Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The life span distribution of autobiographical memory in Alzheimer's disease.
    Kirk M; Berntsen D
    Neuropsychology; 2018 Nov; 32(8):906-919. PubMed ID: 30047758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Healthy and Neuropathological Aging on Autobiographical Memory: A Meta-Analysis of Studies Using the Autobiographical Interview.
    Simpson S; Eskandaripour M; Levine B
    J Gerontol B Psychol Sci Soc Sci; 2023 Oct; 78(10):1617-1624. PubMed ID: 37224530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Longitudinal Study of Episodic and Semantic Autobiographical Memory in aMCI and Alzheimer's Disease Patients.
    Meléndez JC; Pitarque A; Delhom I; Real E; Abella M; Satorres E
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34202299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considering the role of semantic memory in episodic future thinking: evidence from semantic dementia.
    Irish M; Addis DR; Hodges JR; Piguet O
    Brain; 2012 Jul; 135(Pt 7):2178-91. PubMed ID: 22614246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Directed forgetting of autobiographical memory in mild Alzheimer's disease.
    Haj ME; Postal V; Gall DL; Allain P
    Memory; 2011 Nov; 19(8):993-1003. PubMed ID: 22092105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment.
    Sanabria-Diaz G; Demonet JF; Rodriguez-Herreros B; Draganski B; Kherif F; Melie-Garcia L
    Neuroimage Clin; 2021; 32():102799. PubMed ID: 34469849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
    Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
    Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.